DZD completes $8.6M series A round

World |  News | 0 Comment | 28 Jan, 2019

US based start-up, Day Zero Diagnostics, Inc. (DZD) which is an infectious disease diagnostic company using genome sequencing and machine learning to enable rapid and precise treatment in a...Read more

The BHF call for proposals under Big Beat Challenge

World |  News | 0 Comment | 25 Jan, 2019

The British Heart Foundation (BHF) is calling for researchers and innovators from around the world to apply for one of the largest research grants of its kind in history.  The ch...Read more

Merck enters into an exclusive licensing agreement with Vertex

World |  News | 0 Comment | 25 Jan, 2019

Merck, a leading science and technology company has announced that it has entered into an exclusive licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA for two DNA-dep...Read more

deCODE publishes the first genetic map of the Human Genome

World |  News | 0 Comment | 25 Jan, 2019

Scientists at deCODE genetics in Iceland, a subsidiary of Amgen has published the first genetic map of the human genome developed using whole-genome sequence data. The map provides the most...Read more

NIH collaborates with AAS and Bill & Melinda Gates

World |  News | 0 Comment | 25 Jan, 2019

NIH, the African Academy of Sciences, and the Bill & Melinda Gates Foundation are collaborating to establish the African Postdoctoral Training Initiative. Ten African scientists have b...Read more

Eppendorf & Science Prize for Neurobiology 2019: Call for Entries!

World |  News | 0 Comment | 25 Jan, 2019

Eppendorf and the journal Science are now accepting applications for the 2019 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is award...Read more

Alvotech raises $300mn to further biosimilar development

World |  News | 0 Comment | 24 Jan, 2019

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and...Read more

Philogen signs drug discovery contract with J & J

World |  News | 0 Comment | 24 Jan, 2019

Philogen S.p.A., a privately-owned biotechnology company, has announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of...Read more

SSB offers services for characterization of NBEs

World |  News | 0 Comment | 24 Jan, 2019

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of services for new biological entities, called NBE Product Charact...Read more

Vertex announces EC approval for ORKAMBI

World |  News | 0 Comment | 24 Jan, 2019

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatm...Read more

Attune Pharma announces $23M Series B Financing

World |  News | 0 Comment | 24 Jan, 2019

Clinical Stage biotech company, Attune Pharmaceuticals focused on the discovery and development of novel, orally administered, small molecule therapeutics for the treatment of rare diseases...Read more

Translate Bio announces FDA clinical hold on IND

World |  News | 0 Comment | 23 Jan, 2019

Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunct...Read more

Editas Medicine announces CEO Transition

World |  News | 0 Comment | 23 Jan, 2019

Genome editing company, Editas Medicine has announced that Katrine Bosley has decided to step down from her role as President and CEO, effective March 1, 2019. Bosley has al...Read more

Novo Holdings invests 4.4M Euro in Minerva to combat AMR

World |  News | 0 Comment | 23 Jan, 2019

MinervaX, a privately held Danish biotech company has announced that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to ...Read more

J&J reports 2018 fourth-quarter results

World |  News | 0 Comment | 23 Jan, 2019

Johnson & Johnson has announced sales of $20.4 billion for the fourth quarter of 2018, an increase of 1.0% as compared to the fourth quarter of 2017. Operational sales results increased...Read more

Wren Therapeutics completes £18M Series A Financing

World |  News | 0 Comment | 23 Jan, 2019

UK based biopharma company, Wren Therapeutics focused on drug discovery and development for protein misfolding diseases has announced that it has completed a Series A financing round. The ...Read more

Gamida Cell collaborates with Be The Match BioTherapies

World |  News | 0 Comment | 23 Jan, 2019

Clinical stage Biopharmaceutical Company, Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and so...Read more

Redx to resume RXC004 clinical trial programme

World |  News | 0 Comment | 22 Jan, 2019

UK based Biotechnology Company, Redx has announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval to the Company to re-commence the...Read more